QIAGEN

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QIAGEN and other ETFs, options, and stocks.

About QGEN

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. 

CEO
Thierry L. Bernard
CEOThierry L. Bernard
Employees
5,654
Employees5,654
Headquarters
Venlo, Limburg
HeadquartersVenlo, Limburg
Founded
1996
Founded1996
Employees
5,654
Employees5,654

QGEN Key Statistics

Market cap
6.81B
Market cap6.81B
Price-Earnings ratio
17.07
Price-Earnings ratio17.07
Dividend yield
0.80%
Dividend yield0.80%
Average volume
2.90M
Average volume2.90M
High today
$33.63
High today$33.63
Low today
$32.74
Low today$32.74
Open price
$33.45
Open price$33.45
Volume
1.65M
Volume1.65M
52 Week high
$57.82
52 Week high$57.82
52 Week low
$32.74
52 Week low$32.74

Stock Snapshot

With a market cap of 6.81B, QIAGEN(QGEN) trades at $32.74. The stock has a price-to-earnings ratio of 17.07 and currently yields dividends of 79.6%.

On 2026-05-09, QIAGEN(QGEN) stock moved within a range of $32.74 to $33.63. With shares now at $32.74, the stock is trading 0.0% above its intraday low and -2.7% below the session's peak.

Trading activity shows a volume of 1.65M, compared to an average daily volume of 2.9M.

The stock's 52-week range extends from a low of $32.74 to a high of $57.82.

The stock's 52-week range extends from a low of $32.74 to a high of $57.82.

QGEN News

Simply Wall St 2h
Assessing Qiagen Valuation After A Sharp Multi‑Month Share Price Pullback

Advertisement Context on Qiagen’s recent share performance Qiagen (QGEN) has drawn attention after a run of weaker returns, with the stock down about 3% over...

Assessing Qiagen Valuation After A Sharp Multi‑Month Share Price Pullback
TipRanks 2d
Qiagen holds profit targets as Q1 2026 results expose QuantiFERON drag

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

TipRanks 2d
Qiagen Files U.S. GAAP Quarterly Report for First Quarter 2026

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Analyst ratings

59%

of 22 ratings
Buy
40.9%
Hold
59.1%
Sell
0%

More QGEN News

TipRanks 2d
Qiagen price target lowered to $40 from $46 at TD Cowen

TD Cowen analyst Dan Brennan lowered the firm’s price target on Qiagen (QGEN) to $40 from $46 and keeps a Hold rating on the shares. The firm updated its model...

The Motley Fool 3d
Qiagen Q1 2026 Earnings Transcript

Image source: The Motley Fool. Thursday, May 7, 2026 at 9:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Thierry Bernard Vice President, QuantiFERON —...

Qiagen Q1 2026 Earnings Transcript
TipRanks 3d
Qiagen reports Q1 EPS 54c, consensus 54c

Reports Q1 revenue $492M, one estimate $499.2M. “QIAGEN (QGEN) made important progress across many areas of the portfolio in the first quarter, led by solid sal...

People also own

Based on the portfolios of people who own QGEN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.